search button
Open Access

Interplay of retinol binding protein 4 with obesity and associated chronic alterations (Review)

  • Authors:
    • Yaccil Adilene Flores-Cortez
    • Martha I. Barragán-Bonilla
    • Juan M. Mendoza-Bello
    • Cecilia González-Calixto
    • Eugenia Flores-Alfaro
    • Mónica Espinoza-Rojo

  • View Affiliations

  • Published online on: June 1, 2022     https://doi.org/10.3892/mmr.2022.12760
  • Article Number: 244

  • Copyright: © Flores-Cortez et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Obesity is a multifactorial disease, defined as excessive fat deposition in adipose tissue. Adipose tissue is responsible for the production and secretion of numerous adipokines that induce metabolic disorders. Retinol‑binding protein 4 (RBP4) is an adipokine that transports vitamin A or retinol in the blood. High levels of RBP4 are associated with development of metabolic disease, including obesity, insulin resistance (IR), metabolic syndrome, and type 2 diabetes (T2D). The present review summarizes the role of RBP4 in obesity and associated chronic alterations. Excessive synthesis of RBP4 contributes to inflammatory characteristic of obesity by activation of immune cells and release of proinflammatory cytokines, such as TNFα and ILs, via the Toll‑like receptor/JNK pathway. The retinol‑RBP4 complex inhibits insulin signaling directly in adipocytes by activating Janus kinase 2 (JAK2)/STAT5/suppressor of cytokine signaling 3 signaling. This mechanism is retinol‑dependent and requires vitamin A receptor stimulation by retinoic acid 6 (STRA6). In muscle, RBP4 is associated with increased serine 307 phosphorylation of insulin receptor substrate‑1, which decreases its affinity to PI3K and promotes IR. In the liver, RBP4 increases hepatic expression of phosphoenolpyruvate carboxykinase, which increases production of glucose. Elevated serum RBP4 levels are associated with β‑cell dysfunction in T2D via the STRA6/JAK2/STAT1/insulin gene enhancer protein 1 pathway. By contrast, RBP4 induces endothelial inflammation via the NF‑κB/nicotinamide adenine dinucleotide phosphate oxidase pathway independently of retinol and STRA6, which stimulates expression of proinflammatory molecules, such as vascular cell adhesion molecule 1, E‑selectin, intercellular adhesion molecule 1, monocyte chemoattractant protein 1 and TNFα. RBP4 promotes oxidative stress by decreasing endothelial mitochondrial function; overall, it may serve as a useful biomarker in the diagnosis of obesity and prognosis of associated disease, as well as a potential therapeutic target for treatment of these diseases.
View Figures
View References

Related Articles

Journal Cover

July-2022
Volume 26 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 3.4
  • Ranked Medicine Research and Experimental
    (total number of cites)
  • CiteScore: 6.9
  • CiteScore Rank: Q2: #98/328 Biochemistry, Genetics and Molecular Biology
  • Source Normalized Impact per Paper (SNIP): 0.721
  • SCImago Journal Rank (SJR): 0.65
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Flores-Cortez YA, Barragán-Bonilla MI, Mendoza-Bello JM, González-Calixto C, Flores-Alfaro E and Espinoza-Rojo M: Interplay of retinol binding protein 4 with obesity and associated chronic alterations (Review). Mol Med Rep 26: 244, 2022
APA
Flores-Cortez, Y.A., Barragán-Bonilla, M.I., Mendoza-Bello, J.M., González-Calixto, C., Flores-Alfaro, E., & Espinoza-Rojo, M. (2022). Interplay of retinol binding protein 4 with obesity and associated chronic alterations (Review). Molecular Medicine Reports, 26, 244. https://doi.org/10.3892/mmr.2022.12760
MLA
Flores-Cortez, Y. A., Barragán-Bonilla, M. I., Mendoza-Bello, J. M., González-Calixto, C., Flores-Alfaro, E., Espinoza-Rojo, M."Interplay of retinol binding protein 4 with obesity and associated chronic alterations (Review)". Molecular Medicine Reports 26.1 (2022): 244.
Chicago
Flores-Cortez, Y. A., Barragán-Bonilla, M. I., Mendoza-Bello, J. M., González-Calixto, C., Flores-Alfaro, E., Espinoza-Rojo, M."Interplay of retinol binding protein 4 with obesity and associated chronic alterations (Review)". Molecular Medicine Reports 26, no. 1 (2022): 244. https://doi.org/10.3892/mmr.2022.12760